Skip to main contentSkip to navigation
Sirius Investors

BXRXQ Stock: Baudax Bio, Inc. Stock Price, Analysis & Insights

Get live BXRXQ stock price $0.00, comprehensive Baudax Bio, Inc. stock analysis, charts, news, and expert forecast. Real-time BXRXQ stock data and investment insights.

0.00
0.00%Today
BXRXQBaudax Bio, Inc. • Other OTC • Healthcare
Market Cap
4.36K
Volume
1
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Baudax Bio, Inc., a biopharmaceutical company established in Malvern, Pennsylvania in 2019, specializes in developing and commercializing therapeutic solutions for hospital and acute care environments. Their marketed product, ANJESO (meloxicam inject...

Company Information

CEO
Geraldine A. Henwood
Sector
Healthcare
Industry
Biotechnology
Employees
9

Contact Information

Address
490 Lapp Road
Country
US

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: -11.87) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Baudax Bio, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Baudax Bio, Inc.
  • Investors should consider how Baudax Bio, Inc. fits within their overall portfolio allocation

Market Cap

4.36K

Beta

-11.87

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.